We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Sanofi-aventis and the Drugs for Neglected Diseases initiative (DNDi) have introduced a new fixed-dose combination malaria drug containing artesunate and amodiaquine -- called ASAQ -- in Sub-Saharan Africa.
The FDA ordered 20 companies to stop manufacturing unapproved drug products containing ergotamine tartrate as part of the agency's safety efforts to keep unapproved drugs off the market.
Zentiva, based in the Czech Republic, announced it has entered the Hungarian pharmaceutical market by acquiring certain generic products, personnel and other operating assets from sanofi-aventis.
Merck said in an announcement this week about Gardasil -- the company's human papillomavirus vaccine -- that it plans to make the vaccine available in India.
The Vienna, Austria-based U.N. International Narcotics Control Board (INCB) has issued a report warning of the unregulated sales of both controlled and counterfeit drugs.
EvoGenix and Vegenics, both based in Australia, have entered into a technology collaboration agreement in which EvoGenix will apply its proprietary technologies for antibody optimization to assist Vegenics in developing an antibody therapeutic targeting vascular endothelial growth factor D (VEGF-D).
An official with Médecins Sans Frontières (MSF) has told the U.N.'s Integrated Regional Information Networks (IRIN) that efforts to control a meningitis outbreak in Uganda could be hindered by a vaccine shortage.
Pfizer announced yesterday that a federal court in the Western District of Pennsylvania has upheld the company's U.S. patent covering the active ingredient in Norvasc, a hypertension drug.